Interferon-α treatment of patients with hepatitis C: The role of a comprehensive risk-benefit assessment (multiple letters)

Muhamad Aly Rifai, Jennifer M. Loftis, Peter Hauser, Charles L. Raison, Marina Demetrashvili, Lucile Capuron, Andrew H. Miller

Research output: Contribution to journalLetter

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)719-721
Number of pages3
JournalCNS Drugs
Volume19
Issue number8
DOIs
StatePublished - Jan 1 2005

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this